411 related articles for article (PubMed ID: 29869444)
21. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
23. Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands.
Helsing P; Togsverd-Bo K; Veierød MB; Mørk G; Haedersdal M
Br J Dermatol; 2013 Nov; 169(5):1087-92. PubMed ID: 23855503
[TBL] [Abstract][Full Text] [Related]
24. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Heerfordt IM; Bieliauskiene G; Wulf HC
Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
[TBL] [Abstract][Full Text] [Related]
25. Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.
Ko DY; Jeon SY; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1529-39. PubMed ID: 24341367
[TBL] [Abstract][Full Text] [Related]
26. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM
Acta Derm Venereol; 2005; 85(5):424-8. PubMed ID: 16159735
[TBL] [Abstract][Full Text] [Related]
27. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
28. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
[TBL] [Abstract][Full Text] [Related]
30. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
31. Treating Field Cancerization by Ablative Fractional Laser and Indoor Daylight: Assessment of Efficacy and Tolerability.
Paasch U; Said T
J Drugs Dermatol; 2020 Apr; 19(4):425-427. PubMed ID: 32272521
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
[TBL] [Abstract][Full Text] [Related]
33. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Lee PK; Kloser A
J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
[TBL] [Abstract][Full Text] [Related]
34. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
35. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
Braathen LR; Paredes BE; Saksela O; Fritsch C; Gardlo K; Morken T; Frølich KW; Warloe T; Solér AM; Ros AM
J Eur Acad Dermatol Venereol; 2009 May; 23(5):550-5. PubMed ID: 19415804
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
37. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
Szeimies RM; Matheson RT; Davis SA; Bhatia AC; Frambach Y; Klövekorn W; Fesq H; Berking C; Reifenberger J; Thaçi D
Dermatol Surg; 2009 Apr; 35(4):586-92. PubMed ID: 19309347
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
39. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S
J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799
[TBL] [Abstract][Full Text] [Related]
40. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
Kim HJ; Song KH
J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]